Education
About Us
Working with TipRanks
Follow Us
Precision System Science Co.,Ltd (JP:7707)
:7707
RESEARCH TOOLSreports
Top Page
Precision System Science Co.,Ltd
(7707)
42Neutral
Precision System Science Co.,Ltd (7707) vs. S&P 500 (SPY)
Market Cap
¥5.28B
Dividend YieldN/A
Average Volume (3M)218.15K
Price to Earnings (P/E)―
Beta (1Y)1.09
Revenue Growth-0.04%
EPS Growth65.32%
CountryJP
Employees158
SectorHealthcare
Sector Strength48
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)-2.77
Shares Outstanding27,666,900
10 Day Avg. Volume56,130
30 Day Avg. Volume218,146
Financial Highlights & Ratios
PEG Ratio-0.27
Price to Book (P/B)1.65
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Precision System Science Co.,Ltd Business Overview & Revenue Model
Company DescriptionPrecision System Science Co., Ltd. (7707) is a Japanese company that specializes in the development, manufacturing, and sale of automated systems for life sciences and biotechnology applications. The company focuses on providing solutions that enhance the efficiency and effectiveness of laboratory processes, offering products such as automated DNA extraction instruments and reagents. With a commitment to innovation, Precision System Science aims to support the healthcare and research industries by delivering advanced technologies for genomic and molecular diagnostics.
How the Company Makes MoneyPrecision System Science Co., Ltd. generates revenue primarily through the sale of its automated laboratory instruments and related consumables. The company offers a range of products designed to automate and streamline laboratory workflows, particularly in the field of molecular diagnostics. These products include automated nucleic acid extraction systems and the associated reagents and consumables required for their operation. The company also collaborates with research institutions and healthcare providers, providing customized solutions and systems integration services, which form another key revenue stream. Additionally, Precision System Science may engage in strategic partnerships and collaborations to expand its market reach and enhance its product offerings, contributing to its overall earnings.
Precision System Science Co.,Ltd Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | |||||
| TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 4.16B | 3.98B | 5.28B | 7.43B | 9.30B | 5.07B | Gross Profit |
| 1.05B | 950.38M | 1.35B | 2.49B | 3.10B | 1.56B | EBIT |
| -662.35M | -956.25M | -1.11B | 152.38M | 895.29M | -82.41M | EBITDA |
| -160.58M | -661.75M | -594.05M | 740.33M | 1.16B | 18.83M | Net Income Common Stockholders |
| -549.77M | -1.12B | -1.32B | 45.34M | 795.99M | -114.28M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 1.72B | 1.92B | 2.45B | 2.76B | 4.04B | 2.11B | Total Assets |
| 5.95B | 6.40B | 9.76B | 11.41B | 11.57B | 6.44B | Total Debt |
| 1.23B | 1.37B | 3.87B | 4.02B | 3.69B | 1.01B | Net Debt |
| -490.00M | -548.59M | 1.42B | 1.26B | -352.22M | -1.10B | Total Liabilities |
| 1.98B | 2.25B | 4.54B | 4.90B | 4.99B | 2.12B | Stockholders Equity |
| 3.97B | 4.14B | 5.22B | 6.51B | 6.58B | 4.32B |
| Cash Flow | Free Cash Flow | ||||
| 0.00 | -130.81M | -162.03M | -1.38B | -2.09B | -251.76M | Operating Cash Flow |
| 0.00 | -106.80M | -6.75M | 869.16M | -280.97M | -21.45M | Investing Cash Flow |
| 0.00 | 2.06B | -213.70M | -2.29B | -1.81B | -214.08M | Financing Cash Flow |
| 0.00 | -2.51B | -154.05M | 93.73M | 4.00B | 510.79M |
Precision System Science Co.,Ltd Technical Analysis
Neutral
191.00
Price Trends
208.92
Negative
222.36
Negative
249.87
Negative
Market Momentum
-4.70
Negative
44.02
Neutral
53.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7707, the sentiment is Neutral. The current price of 191 is above the 20-day moving average (MA) of 190.10, below the 50-day MA of 208.92, and below the 200-day MA of 249.87, indicating a neutral trend. The MACD of -4.70 indicates Negative momentum. The RSI at 44.02 is Neutral, neither overbought nor oversold. The STOCH value of 53.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7707.
Precision System Science Co.,Ltd Peers Comparison
Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $1.65T | 28.48 | 13.12% | 1.15% | 14.50% | 29.02% | |
74 Outperform | $6.12T | 20.89 | 17.60% | 1.65% | 17.77% | 48.97% | |
69 Neutral | $2.27T | 27.74 | 15.47% | 1.04% | 7.60% | -66.30% | |
66 Neutral | ¥70.16B | 34.86 | 2.38% | 0.74% | -20.80% | ||
57 Neutral | ¥445.59B | 79.81 | 0.91% | 3.24% | 0.01% | -54.41% | |
52 Neutral | $5.21B | 3.49 | -43.30% | 2.83% | 14.70% | -0.24% | |
42 Neutral | ¥5.28B | ― | ― | -0.04% | 65.32% |
* Healthcare Sector Average
Performance Comparison
JP:7707
Precision System Science Co.,Ltd
191.00
-7.00
-3.54%
JP:4549
Eiken Chemical Co., Ltd.
2,224.00
102.03
4.81%
JP:6869
Sysmex
2,640.00
13.10
0.50%
JP:7731
Nikon
1,425.50
-226.77
-13.72%
JP:4568
Daiichi Sankyo Company
3,517.00
-1,821.59
-34.12%
JP:7733
Olympus
2,017.00
-464.16
-18.71%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.